James L Riley

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Men Who Have Sex With Men

Antiretroviral Therapy

Dna Methylation

Regulatory T Cells

Top Venues

Nature medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Zhenguo Zi, Shujuan Du, Liming Zhang, Yuebo Wang, Ling Ding, Chongqi Zhang, Huanyu Wang, Jan Pawlicki, Yuan Cai, Yazhou Yao, Feng Zhou, Yin Tong, James L Riley, Qiliang Cai, Xiaojing Ma, Fang Wei
Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability. Blood advances (2023)
Caimei Zhang, Siddhant Kadu, Yansen Xiao, Omar Johnson, Andre R Kelly, Roderick O'Connor, Meizan Lai, Hong Kong, Sriram Srivatsa, Victoria Tai, Eli Greenblatt, Matthew Holmes, James L Riley, Carl H June, Neil C Sheppard
Sequential Exposure to Interleukin-21 and Interleukin-15 During Human Natural Killer Cell Expansion Optimizes Yield and Function. Cancer immunology research (2023)
Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Yuqi Zhou, Julie Jadlowsky, Caitlin Baiduc, Alex W Klattenhoff, Zhilin Chen, Alan D Bennett, Nicholas J Pumphrey, Bent K Jakobsen, James L Riley
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS pathogens 19 (12) (2023)
Gloria B Kim, Jens Fritsche, Sebastian Bunk, Andrea Mahr, Felix Unverdorben, Kevin W Tosh, Hong Kong, Colby R Maldini, Chui Lau, Sriram Srivatsa, Shuguang Jiang, Joshua Glover, Derek Dopkin, Carolyn X Zhang, Heiko Schuster, Daniel J Kowalewski, Valentina Goldfinger, Martina Ott, David Fuhrmann, Maike Baues, Hans Boesmueller, Christoph Schraeder, Gisela Schimmack, Colette Song, Franziska Hoffgaard, Michael Roemer, Chih-Chiang Tsou, Martin Hofmann, Thomas Treiber, Meike Hutt, Leonie Alten, Maike Jaworski, Amir Alpert, Sarah Missel, Carsten Reinhardt, Harpreet Singh, Oliver Schoor, Steffen Walter, Claudia Wagner, Dominik Maurer, Toni Weinschenk, James L Riley
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy. Science translational medicine 14 (660) (2022)
Mary M Addison, Gavin I Ellis, George J Leslie, Noah B Zawadzky, James L Riley, James A Hoxie, Laurence C Eisenlohr
HIV-1-Infected CD4 + T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing. Journal of immunology (Baltimore, Md. : 1950) 209 (5) (2022)
Divanshu Shukla, James L Riley
Ultrasensitive antigen density discrimination by synNotch. Cell research 31 (7) (2022)
Gavin I Ellis, James L Riley
How to kill T reg cells for immunotherapy. Nature cancer 1 (12) (2022)
Jan M Pawlicki, David L Cookmeyer, Damian Maseda, John K Everett, Fang Wei, Hong Kong, Qian Zhang, Hong Y Wang, John W Tobias, David M Walter, Kelly M Zullo, Sarah Javaid, Amanda Watkins, Mariusz A Wasik, Frederic D Bushman, James L Riley
NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation. Cancer research 81 (12) (2021)
Gavin I Ellis, Neil C Sheppard, James L Riley
Genetic engineering of T cells for immunotherapy. Nature reviews. Genetics 22 (7) (2021)
Colby R Maldini, Daniel T Claiborne, Ken Okawa, Tao Chen, Derrick L Dopkin, Xiaochuan Shan, Karen A Power, Radiana T Trifonova, Katharine Krupp, Meredith Phelps, Vladimir D Vrbanac, Serah Tanno, Timothy Bateson, George J Leslie, James A Hoxie, Christian L Boutwell, James L Riley, Todd M Allen
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo. Nature medicine 26 (11) (2020)
Rachel S Leibman, Max W Richardson, Christoph T Ellebrecht, Colby R Maldini, Joshua A Glover, Anthony J Secreto, Irina Kulikovskaya, Simon F Lacey, Sarah R Akkina, Yanjie Yi, Farida Shaheen, Jianbin Wang, Keith A Dufendach, Michael C Holmes, Ronald G Collman, Aimee S Payne, James L Riley
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. PLoS pathogens 13 (10) (2017)